CRIS Current Research Information System

ALINARI, LAPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.106
AS - Asia 1.762
EU - Europa 1.381
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 72
SA - Sud America 65
OC - Oceania 2
Totale 5.486
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.073
VN - Vietnam 589
CN - Cina 427
SG - Singapore 402
GB - Regno Unito 375
SE - Svezia 251
DE - Germania 172
IT - Italia 145
HK - Hong Kong 115
UA - Ucraina 87
FR - Francia 78
IN - India 67
RU - Federazione Russa 64
IE - Irlanda 48
BR - Brasile 36
HR - Croazia 30
JO - Giordania 29
JP - Giappone 29
KR - Corea 28
ZA - Sudafrica 27
CI - Costa d'Avorio 26
NL - Olanda 22
CA - Canada 21
FI - Finlandia 21
TG - Togo 21
CH - Svizzera 20
EE - Estonia 17
BE - Belgio 15
PH - Filippine 15
AR - Argentina 12
BD - Bangladesh 10
IR - Iran 10
NG - Nigeria 10
TW - Taiwan 10
PL - Polonia 9
SC - Seychelles 8
BG - Bulgaria 7
ES - Italia 7
ID - Indonesia 6
MX - Messico 6
TH - Thailandia 6
TR - Turchia 5
EC - Ecuador 4
GR - Grecia 4
TN - Tunisia 4
CL - Cile 3
CO - Colombia 3
SA - Arabia Saudita 3
AT - Austria 2
BO - Bolivia 2
IQ - Iraq 2
LB - Libano 2
PA - Panama 2
PY - Paraguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AU - Australia 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HN - Honduras 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.415
Salva come PNG Salva come JPEG
Città #
Southend 316
Singapore 285
Ashburn 192
Chandler 178
Fairfield 176
Ann Arbor 155
Ho Chi Minh City 131
Hong Kong 108
Hanoi 107
Woodbridge 104
Seattle 101
San Jose 100
Houston 97
Wilmington 88
Hefei 87
Cambridge 80
Beijing 68
Jacksonville 60
Santa Clara 60
Princeton 56
Dublin 48
Los Angeles 46
Boardman 42
New York 40
Nanjing 34
Dong Ket 33
Lauterbourg 30
Amman 29
Padova 27
Turin 27
Westminster 27
Abidjan 26
Seoul 25
Tokyo 24
Berlin 21
Lomé 21
Buffalo 19
Haiphong 18
Da Nang 17
Helsinki 16
Munich 16
Saint Petersburg 15
Bern 14
Jinan 14
Council Bluffs 13
Bologna 12
Brussels 12
Milan 12
Nanchang 12
Redwood City 12
Shenyang 12
Florence 11
Abeokuta 10
Frankfurt am Main 10
Hải Dương 10
Biên Hòa 9
Bremen 9
Changsha 9
Chicago 9
Mülheim 9
San Diego 9
Zhengzhou 9
Jiaxing 8
São Paulo 8
Can Tho 7
Guangzhou 7
Sofia 7
Dallas 6
Falkenstein 6
Hebei 6
London 6
Zanjan 6
Dearborn 5
Düsseldorf 5
Ha Long 5
Ningbo 5
Norwalk 5
Quận Bình Thạnh 5
Tianjin 5
Turku 5
Wuhan 5
Bắc Ninh 4
Denver 4
Jakarta 4
Kunming 4
Lausanne 4
Mahé 4
Mumbai 4
Ninh Bình 4
Orem 4
Phoenix 4
Taizhou 4
Toronto 4
Verona 4
Winnipeg 4
Bengaluru 3
Bexley 3
Boston 3
Brooklyn 3
Buenos Aires 3
Totale 3.550
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET early after radiotherapy in lymphoma patients. 320
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. 266
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 255
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. 246
18 F-FDG PET in malignant lymphoma: significance of positive findings 245
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 232
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. 221
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 217
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience 212
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. 211
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 209
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 203
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. 201
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. 198
Discordant response to chemotherapy: An unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients 195
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. 194
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. 186
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. 172
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. 171
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma. 166
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. 162
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. 160
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. 158
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine 150
FDG-PET in the serial assessment of patinets with lymphoma in complete remission 145
Rituximab in primary conjunctiva lymphoma. 142
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 138
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 82
Gemcitabine 29
Totale 5.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022561 0 16 56 97 42 28 14 41 15 39 139 74
2022/2023736 84 88 46 87 57 59 12 32 157 21 58 35
2023/2024150 7 32 9 20 12 41 6 5 3 10 3 2
2024/2025598 10 112 45 41 108 39 31 4 2 45 16 145
2025/20261.606 124 271 128 88 186 101 113 34 332 110 85 34
2026/202724 24 0 0 0 0 0 0 0 0 0 0 0
Totale 5.486